Bubs Australia Ltd shares are down almost 30% in less than two weeks

Unfortunately for its shareholders the Bubs Australia Ltd (ASX: BUB) share price has taken another sharp tumble during trade today.

At the time of writing the baby food and goat milk infant formula company’s shares are down over 9% to 78 cents.

This means Bubs’ shares have lost almost 30% of their value since peaking at $1.10 earlier this month.

What happened?

Bubs’ shares have come under significant pressure this week after one of its major shareholders offloaded over 6.8 million shares on market.

By doing so, Next Step Global Limited reduced its stake in the company to 12.4% from 14.6% previously.

Some investors appear to be interpreting this as a sign that its shares are overvalued and have headed to the exits in order to take profit off the table or limit their losses.

Are Bubs’ shares overvalued?

Based on its current sales Bubs’ shares are vastly overvalued. However, it has positioned itself extremely well to potentially grow its top line significantly in the future.

Through supply agreements with both major online e-commerce platforms and mother and baby stores in China, I believe Bubs has an outside chance of growing into its valuation in the future.

However, I have found its sales growth thus far to be reasonably underwhelming. For all the hard work the company has done in positioning the company, if Chinese consumers don’t take to the product as they have with a2 Milk Company Ltd (Australia) (ASX: A2M) and Bellamy’s Australia Ltd (ASX: BAL), then these supply agreements count for very little.

In light of this, I don’t believe the risk/reward on offer at the moment is compelling enough to make an investment and suggest investors wait to see how its sales develop in the coming quarters.

In the meantime these top small-cap shares could be much better options.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Cochlear or REA Group.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.